Special Bundle Pricing
Now Available

We are offering a powerful clinical solution to capture health data by combining the iBloodPressure® with the iScale®. And for a limited time, get them at a low price that includes 12 months of data. It’s a great way to help patients track blood pressure and weight, two factors that can lead to heart disease, in real time

Contact Us For More Information

Get Closer To The Patient

With Data and Device Infrastructure for
Remote Patient Monitoring and Chronic Care Management

 

 

Rapidly Implement a
Reimbursable RPM Solution

 

SmartRPM offers unmatched data reliability
and cellular-connected devices

 

– iGlucose® – iScale® – iPulseOx® – iBloodPressure®

Learn More


Automatically Collect Blood
Glucose Levels for Optimal
Diabetes Care

iGlucose® delivers health metrics without patient intervention

Learn More

Help for COPD patients is here

iPulseOx®  can help providers keep track of patients with pulmonary disorders with real-time oxygen saturation levels.

Learn More

Real-Time Metrics

iBloodPressure® provides a fast and accurate method for tracking high blood pressure patients

Learn More

Introducing the iScale®

With several unique features, the iScale is optimized for connected care in a patient’s home.

Learn More

Smart Meter is the foundation of the RPM Ecosystem

Smart Meter has propelled virtual care forward with our full suite of cellular-connected, FDA approved devices paired with a robust data management and monitoring platform that helps drive patient engagement.

Smart Meter is the foundation of the RPM Ecosystem

Smart Meter has propelled virtual care forward with our full suite of cellular-connected, FDA approved devices paired with a robust data management and monitoring platform that helps drive patient engagement.

Our Cellular-Connected Devices

US Patent Nos.: 10,311,208; 10,783,987; 10,783,988.  UK Patent No. GB2542056. Canada Patent No. 2953253

Now Available with an Extra-Large Cuff

Our Cellular-Connected Devices

US Patent Nos.: 10,311,208; 10,783,987; 10,783,988.  UK Patent No. GB2542056. Canada Patent No. 2953253

iBloodPressure

iBloodPressure 2.0®

iGlucose®

iScale

iPulseOx®

Current Partners

Join the hundreds of market-leading RPM companies utilizing Smart Meter’s powerful cellular SmartRPM technology.

Smart Meter by the Numbers

350+
Distribution Partners

125,000+
Patients Monitored Daily

2M+
Monthly Patient Tests

99.9%
Device reliability1

Smart Meter by the Numbers

350+
Distribution Partners

125,000+
Patients Monitored Daily

2M+
Monthly Patient Tests

99.9%
Device reliability1

Cellular Remote Patient Monitoring:

Immediate. Reliable. Actionable.

Smart Meter eliminates the complex, extra steps—and delay—of sharing health metrics. All patients do is test by pressing a single button on iGlucose and iBloodPressure or simply stepping on the iScale. Clinicians benefit from access to cellular transmitted, real-time, reliable and secure patient data between visits, which can lead to better patient out comes.

Testimonials

"iGlucose’s ability to send BG data to our platform without syncing, pairing, home hubs or cables, is the perfect solution."
– Joshua Claman, Former Chief Executive Officer, Rimidi
"Data flowing into the population management portal has quickly become an essential tool in managing diabetes for our patients. …iGlucose system drives better outcomes for our patients."
– Joel Okner, MD, Cardiologist
"The iGlucose system with real-time data adds tremendous value to our diabetes education program ... The ability to have real-time data in making therapy decisions has been a huge plus."
– Vivian N. Ayuk, PharmD, CDE, Chief Executive Officer, Flexcare Health Solutions
"Because of the remote patient monitoring available with your iGlucose meters, we will discuss the utility of remote patient monitoring for many patients. I can’t thank your company enough for enabling our future physicians an opportunity to gain an understanding of what they might ask of their future patients. "
– Kathryn R Goldman, MD, Assistant Professor of Medicine, University of Connecticut School of Medicine

News + Events

*Better Data. Better Care. Better Outcomes. Reference: Self-Monitoring of Blood Glucose: A Prerequisite for Diabetes Management in Outcome Trials Oliver Schnell, MD1, Markolf Hanefeld, MD2, and Louis Monnier, MD3

1 – 99.9% of active patients have zero product issues based on over 2 million clinical readings March – August 2021.